OXIS International
skip to menu
skip to primary content
Home
Start Page
Ergothioneine (EGTā¢)
The Intelligent Anti-Oxidant
Reasearch & Development
Consumer Products
Overview of Products
Investors Relations
Information for Investors
Contact OXIS
Get in Touch with OXIS
Investor Relations
Welcome
Company Overview
Leadership
Press Releases
SEC Filings
Webcast: Business Update Conference Call
Company Presentation
Webcast: Lippert/Heilshorn Life Sciences & Medtech & Virtual Conference; February 17, 2011
Company Presentation
OXIS International 2010 Letter to Stockholders
Investor Fact Sheet
Whistleblower Policy
Code of Ethics
Investor Presentation
Price Data
NASDAQ
GTBP
1dy
1mo
6mo
1yr
5yr
Contact Information
David Saloff
Chairman and CEO
424-248-2300
info@oxis.com
Back to Top